|
|
|
|
|
Hit Identification and Hit-to-Lead |
|
|
|
HD Biosciences provides services to our clients for their hit identification and hit-to-lead programs. We undertake assay development in major target classes, such as GPCRs, kinases, ion channels and transporters, and in a high-throughput screening format using plate-based platforms. Our screening capabilities span from cell line generation, biochemical, and cell-based functional assays for receptors, enzymes and ion channels in a |
variety of techniques, including: |
|
• |
|
Fluorescence (e.g. HTRF, FP, FRET, FLIPR, Flexstation) |
• |
Absorbance |
• |
Luminescence (e.g. luciferase, b-lactamase, deGFP, reporter gene) |
• |
Radiometrics (e.g. SPA, MicroBeta, Filtration) |
• |
Electrophysiology (e.g. patch clamps) |
• |
ImageXpress (e.g. live cell image HCA/HCS) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Latest Generation of Auto Patch Clamp Platform Launched at HDB |
|
---------------------- |
WuXi Biology/HD Biosciences Presented at Webinar of "New Technologies for Target Discovery and Validation" |
|
---------------------- |
HD Biosciences Merges with WuXi AppTec |
|
|
|
|
|
|
|
|
|
|